8-K - Medline Inc. (0002046386) (Filer)

424B4 - Medline Inc. (0002046386) (Filer)

EFFECT - Medline Inc. (0002046386) (Filer)

S-1MEF - Medline Inc. (0002046386) (Filer)

S-1 - Medline Inc. (0002046386) (Filer)

SCHEDULE 13G/A - Medline Inc. (0002046386) (Subject)

SCHEDULE 13G/A - Medline Inc. (0002046386) (Subject)

SCHEDULE 13G/A - Medline Inc. (0002046386) (Subject)

10-Q - Medline Inc. (0002046386) (Filer)

8-K - Medline Inc. (0002046386) (Filer)

4 - Medline Inc. (0002046386) (Issuer)

4 - Medline Inc. (0002046386) (Issuer)

4 - Medline Inc. (0002046386) (Issuer)

Agreement with Mohawk Medbuy in Canada marks first-of-its-kind Prime Vendor relationship outside the U.S.NORTHFIELD, Ill., May 29, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in the country and is the first Medline Prime Vendor relationship outside the United States. The agreement is with Mohawk Medbuy (MMC), one of Canada's largest healthcare procurement organizations, to support warehouse and supply chain logistics for its hospitals in Southwestern Ontario and builds from best practices from similar agreements with hundreds of healthcare providers in the U.S.

NORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $37.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 10,883,189 shares of Medline's Class A common stock. Medline did not sell any shares of Class A common stock in the offering and did not recei

NORTHFIELD, Ill., May 27, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that members of the executive leadership team will be participating in the following investor conferences. Mike Drazin, chief financial officer, and Amanda Laabs, chief product officer, are scheduled to present at the William Blair 46th Annual Growth Stock Conference in Chicago, IL, on Wednesday, June 3, 2026, at 3:40pm ET.Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL, on Tuesday, June 9, 2026, at 10:40am ET. Webcasts of the presentations will be a

EscharEx® Phase III VALUE trial advancing; interim assessment and enrollment completion expected by the end of the first quarter of 2027 First quarter revenue of $1.5 million; full-year 2026 revenue guidance reaffirmed at $24-26 million Conference Call Today, May 27, 2026, at 8:30 a.m. Eastern Time YAVNE, Israel, May 27, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the first quarter ended March 31, 2026, and provided a corporate update. "During the first quarter, we continued to advance both our strategic and operational priorities," said Ofer Gonen, Chief Execut

NORTHFIELD, Ill., May 21, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today the pricing of its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $37.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 10,883,189 shares of Medline's Class A common stock. The offering is expected to close on May 28, 2026, subject to customary closing conditions. M

Ready-to-use packs help reduce prep time and improve inventory management, allowing organizations to focus more on patient careNORTHFIELD, Ill., May 20, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced the availability of custom spay/neuter surgical packs designed to help animal shelters and humane societies, high-volume spay and neuter clinics, and veterinary practices streamline procedures, reduce staff burden and help enhance access to spay and neuter programs. Millions of pets are spayed and neutered annually in the United States, and organized surgery packs can group es

NORTHFIELD, Ill., May 20, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") have commenced an underwritten public offering of 60,000,000 shares of Medline's Class A common stock pursuant to a registration statement filed with the Securities and Exchange Commission (the "SEC"). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 9,000,000 shares of Medline's Class A common stock. Medline is not selling any sha

NORTHFIELD Ill., May 18, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) has unveiled a new AutoStore™ installation at its distribution center in Aurora, Colo., as part of an ongoing effort to drive efficiency, optimize fulfillment and increase order capacity amid growing customer demand in the region. This is Medline's 24th AutoStore installation nationwide. AutoStore is an automated storage and retrieval system that uses robots and high-density storage technology to streamline fulfillment, increase throughput and drive distribution efficiency. Medline's AutoStore installation in Au

Net sales of $7.4 billion, an increase of 10.7%Net income of $239 million, a decrease of 25.8%Adjusted EBITDA1 of $776 million, a decrease of 10.6%Raising full year 2026 Organic Sales2 guidance range to 8.5% to 9.5% NORTHFIELD, Ill., May 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline" or the "Company") (NASDAQ:MDLN), the largest provider of medical-surgical ("med-surg") products and supply chain solutions serving all points of care3, today reported its operating results for the three months ended March 28, 2026. "We started 2026 with strong momentum—growing with our existing customers, executing implementations at scale and winning new customers," said Jim Boyle, chief executive off

First wave of Medline customers begin leveraging Mpower to strengthen supply chain resiliencyNORTHFIELD, Ill., May 4, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced that its cloud-based, AI-powered supply chain technology called Mpower™ is now available to help healthcare providers anticipate and respond to potential disruptions before they impact patient care. Built in collaboration with Microsoft and developed with direct input from health systems across the country, Mpower represents a significant step forward in modernizing healthcare supply chain decision-making. The

Citigroup resumed coverage of Medline with a rating of Buy and set a new price target of $60.00

Tigress Financial initiated coverage of Medline with a rating of Buy and set a new price target of $55.00

BTIG Research reiterated coverage of Medline with a rating of Buy and set a new price target of $55.00 from $50.00 previously

Citigroup initiated coverage of Medline with a rating of Buy and set a new price target of $48.00

BNP Paribas Exane initiated coverage of Medline with a rating of Neutral and set a new price target of $38.00

Piper Sandler initiated coverage of Medline with a rating of Overweight and set a new price target of $50.00

Morgan Stanley initiated coverage of Medline with a rating of Overweight and set a new price target of $48.00

Analyst initiated coverage of Medline with a rating of Overweight and set a new price target of $50.00

RBC Capital Mkts initiated coverage of Medline with a rating of Outperform and set a new price target of $47.00

Mizuho initiated coverage of Medline with a rating of Outperform and set a new price target of $48.00

EscharEx® Phase III VALUE trial advancing; interim assessment and enrollment completion expected by the end of the first quarter of 2027 First quarter revenue of $1.5 million; full-year 2026 revenue guidance reaffirmed at $24-26 million Conference Call Today, May 27, 2026, at 8:30 a.m. Eastern Time YAVNE, Israel, May 27, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the first quarter ended March 31, 2026, and provided a corporate update. "During the first quarter, we continued to advance both our strategic and operational priorities," said Ofer Gonen, Chief Execut

Net sales of $7.4 billion, an increase of 10.7%Net income of $239 million, a decrease of 25.8%Adjusted EBITDA1 of $776 million, a decrease of 10.6%Raising full year 2026 Organic Sales2 guidance range to 8.5% to 9.5% NORTHFIELD, Ill., May 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline" or the "Company") (NASDAQ:MDLN), the largest provider of medical-surgical ("med-surg") products and supply chain solutions serving all points of care3, today reported its operating results for the three months ended March 28, 2026. "We started 2026 with strong momentum—growing with our existing customers, executing implementations at scale and winning new customers," said Jim Boyle, chief executive off

NORTHFIELD, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report first quarter 2026 financial results on Wednesday, May 6, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline's financial results, including a link to the live webcast, will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedline is the largest pr

NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline's financial results, including a link to the live webcast, will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedli